Tissue oximetry (StO 2 ) plus a vascular occlusion test is a noninvasive technology that targets indices of oxygen uptake and delivery. We hypothesize that prehospital tissue oximetric values and vascular occlusion test response can predict the need for in-hospital lifesaving interventions (LSI).
P
rehospital evaluation of trauma patients relies on evaluating vital signs and mechanism of injury, which often do not predict a need for interventions or outcomes. 1, 2 Vital signs such as blood pressure and heart rate may not change until patients reach decompensated shock, preventing early recognition and treatment. [2] [3] [4] [5] [6] Delayed identification of hypoperfusion may lead to triage of some patients away from specialized trauma centers and to inadequate or delayed resuscitation which is strongly associated with an increase in infection, multiorgan dysfunction (MOD), and mortality. 3, 7, 8 Uncontrolled hemorrhage and resultant shock account for up to 82% of early operative deaths after trauma. 9 Early aggressive resuscitation of critically ill patients may limit or reverse tissue hypoxia progressing to organ failure. 10 Currently used monitoring technology for prehospital evaluation is inadequate for identifying hemorrhage-induced tissue hypoxia. Early identification of tissue hypoxia is necessary to implement timely and corrective lifesaving interventions (LSI). 11 These interventions may include blood transfusion and emergent operative intervention (thoracotomy, laparotomy, pelvic fixation, and embolization) and admission to the intensive care unit.
Many patients have compromised regional oxygen delivery despite adequate hemodynamic parameters. 7, 8 Therefore, prehospital vital signs such as blood pressure, heart rate, and oxygen saturation may not significantly deviate from normal values due to the patient's physiologic compensatory mechanisms. This may lead to delayed identification of hypoperfusion and inadequate resuscitation in patients with compensated shock.
Tissue oximetry (StO 2 ) is a noninvasive, near-infrared spectroscopy-based monitoring technology that targets both global and regional indices of oxygen uptake and delivery. StO 2 allows medical providers to identify critically ill patients with a high risk of developing hemorrhage-induced organ dysfunction. 12, 13 Evidence suggests that a low tissue oxygen ratio (PtO 2 /FiO 2 ) is indicative of poor tissue perfusion/oxygenation and is associated with a high incidence of organ failure. 12, 13 Previous studies have also shown that tissue oxygen saturation (StO 2 ) is predictive of an increase in the MOD scale and mortality when assessed within 1 hour of emergency department arrival performs similarly to base deficit but has the benefit of being noninvasive and continuously monitored. 10 Real-time measurement of StO 2 allows for dynamic assessment of patient response to resuscitation.
Additional data can be obtained from a vascular occlusion test (VOT), a regional stress test, which may be more sensitive and specific than vital signs alone for the identification of shock. 14, 15 During the VOT, a pneumatic cuff occludes blood flow proximal to the sensor resulting in deoxygenation of the tissue. The rate of deoxygenation (DeO 2 ) is thought to reflect the local metabolic rate, which is effected by states of shock. Subsequently, the cuff is released. The rate of reoxygenation (ReO 2 ), which reflects the time required to wash out stagnant blood, is thought to be determined by local cardiovascular reserve and microcirculatory flow. These rates of deoxygenation and reoxygenation will be referred to as VOT-derived parameters. We hypothesize that prehospital tissue oximetric values and the response to a VOT can predict the need for in-hospital LSI, defined as the need for emergent operation or emergent transfusion in the first 24 hours of hospitalization.
METHODS
Following approval of this study by the University of Pittsburgh Institutional Review Board, we conducted a prospective, blinded, observational study to evaluate the ability of near-infrared spectroscopy StO 2 (InSpectra StO 2 ; Hutchinson Industries, Hutchinson, MN) in conjunction with a VOT to provide early detection of shock states in trauma patients arriving to a single Level I trauma center in Pittsburgh, Pennsylvania.
We equipped six rotor wing aircraft with StO 2 monitors covering a catchment area of approximately 4 million people. The emergency department, with 50,000 annual visits, serves an urban, academic teaching hospital with 700 beds and is a Level I trauma center with more than 5,000 trauma admissions a year. The study inclusion criteria were age Ն18 years, transport on a StO 2 equipped aircraft, and admission to the trauma service. We excluded prisoners, known pregnant females, and those with bilateral forearm injuries. We instructed crews not to perform the VOT on an injured extremity. The study period encompasses 9 months, during which StO 2 measurements were obtained during the critical care transport.
Flight crews applied the StO 2 monitor to the thenar eminence of eligible trauma patients in flight to a Level I Trauma Center and performed a VOT. Data recorded during the VOT were used to generate DeO 2 and ReO 2 . Providers were blinded to DeO 2 and ReO 2 results, as the evaluation of these parameters required post hoc computer analysis and was not available in real time. No change in clinical care was initiated during the flight based on these observational data.
All trauma patients had automated and continuous monitoring with LIFEPAK 12 monitors (PhysioControl, Redmond, WA) sampling vital signs every 5 minutes of transport. A single point of care lactate (Arkray Lactate Pro, Kyoto, Japan) was obtained upon patient contact. After each patient transport, prehospital providers transcribed vital signs into an electronic medical record (EMS Charts, West Mifflin, PA). A narrative of injury, medications administered, point of care prehospital lactate, and changes in patient condition were recorded on the prehospital record.
From the prehospital database, the patient's demographics, date of service, vital signs, and treatment were downloaded, and probabilistic linkage was used to identify the in-hospital record using time and date of service. Inhospital medical records were used to record outcome information. Medical record number was linked to in-hospital record using date of service. Three investigators (H.G., J.M., and J.Q.) used a standardized data collection sheet to record all de-identified prehospital and outcome data.
Injury severity score (ISS) was calculated as previously described. 16 Emergent operation was defined as any of the following procedures performed for hemorrhage control in the first 24 hours of hospitalization: thoracotomy, laparotomy, pelvic fixation, and embolization. Emergent transfusion was defined as a patient receiving blood in the first 24 hours of hospitalization. The trigger for transfusion is hypotension (systolic blood pressure (SBP) Ͻ90 mm Hg) not responsive to 2 L of crystalloid or at the discretion of the command physician (prehospital) or trauma surgeon (trauma bay). The primary outcome was the ability to predict these LSI.
Data are presented as mean Ϯ standard deviation or median (25-75 interquartile range [IQR]) for non-Gaussian variables. Comparison of the two groups was performed using Kruskal-Wallis test or one-way analysis of variance for continuous variables and the 2 statistics for comparing categorical variables. We calculated DeO 2 and ReO 2 slopes using linear regression. We determined the DeO 2 slope using Pearson's coefficients of regression (r 2 ) for the first 25% of descent and the reoxygenation slopes using the entire recovery interval to baseline values as previously described. 14 We used univariate logistic regression models to determine the association of demographics; prehospital vital signs; baseline StO 2 , DeO 2 , and ReO 2 curves; and outcomes (LSI). From these results, we created a multivariate model to account for age, Glasgow Coma Scale (GCS), and vital signs as covariates in predicting LSI. A parametric receiver operating characteristic curve was generated and the area under the curve was calculated. The Hosmer-Lemeshow statistic is reported to assess the performance of the model. Analysis was performed using STATA software (version 10; STATA Inc, College Station, TX).
RESULTS
The StO 2 device was applied in a convenience sample of 150 trauma patients transported by a single critical care transport service from April to November of 2009. The age range of the patients was 18 years to 98 years (mean, 47 years) and 60% were men. In-hospital mortality was 3% (95% confidence interval [CI], 1.1-7.6); 31% (95% CI, 24 -39) were admitted to the intensive care unit, 6% (95% CI, 2.8 -11.1) had an emergent operation, 10% (95% CI, 5.7-15.9) required transfusion, 3% required both transfusion and emergent operation, 10% were treated with prehospital intubation, and 19% required mechanical ventilation. The median length of mechanical ventilation was 2.5 days (IQR, 1-6 days).
StO 2 measurements were obtained a median of 48 minutes (IQR, 40 -64) from the time of injury. When the time of injury was not available, the time of EMS dispatch was used as a surrogate. Among those patients requiring LSI, 31 arrived directly from the scene whereas 21 were transported from other hospitals. The initial mean StO 2 level was 78 (Ϯ8), median DeO 2 was 0.17%/s (IQR, 0.12-0.21), and median ReO 2 was 2.4%/s (IQR, 1.3-3.6). DeO 2 and ReO 2 are poorly associated with field lactate measurements (r ϭ 0.13 and r ϭ 0.17, respectively). As detailed in Table 1 , differences were apparent in the distribution of injury among those requiring LSI: less extremity trauma, more head, chest, and abdominal trauma. Initial prehospital vital signs did not differ between the LSI group versus those that did not require LSI ( Table 1 ). The median ISS for patients requiring an LSI was 16 (IQR, 9 -25) while those who did not need LSI had a median ISS of 5 (IQR, 1-10). Only 8 of 52 (15%) patients with the combined outcome had an episode of prehospital hypotension below 90 mm Hg. An abnormal DeO 2 slope would have identified 29 of 52 (56%) patients requiring LSI and 7 of 8 (88%) hypotensive patients requiring LSI. A higher proportion of patients with abnormal mental status exist in the LSI cohort.
Decreasing DeO 2 and ReO 2 are associated with increasing ISS. As ReO 2 values decreased, the proportion of survivors decreased. Neither DeO 2 nor ReO 2 ( Fig. 1 ) correlated with SBP. Decreasing DeO 2 was associated with a higher proportion of patients requiring LSI. The fitted receiver operating characteristic for DeO 2 as a predictor of LSI is shown in Figure 2 . The time from StO 2 VOT to LSI procedure was a median of 237 minutes (IQR, 154 -858). Intervention occurred within 2 hours in 3 of 12 cases and 6 of 12 within 2 hours to 12 hours with only three requiring Ͼ12 hours. Univariate relationships were identified between death and ReO 2 , GCS, and age; however, the small number of deaths precluded any attempt at performing a multivariate analysis. The need for LSI has a univariate association with DeO 2 , lowest SBP, and GCS. In the multivariate model, the association between the need for LSI and DeO 2 , GCS, and age persists (Table 2 ). Other than lowest SBP, there is no association between prehospital vital signs and outcomes.
DISCUSSION
In a large convenience sample of prehospital patients being transported to a Level I trauma center, a measure- found to be associated with injury severity and the need for LSI. More importantly, the relationship between DeO 2 and need for LSI is independent of the presence of other available prehospital information, including vital signs and mental status. The VOT requires approximately 3 minutes to perform using an automated tourniquet. Graphical data produced by the VOT can be viewed in real time; however, additional education of the flight crews would be necessary to teach them how to interpret the data. Currently, the slope calculations are done post hoc after extracting the raw data from the machine. Modifications of the current software could perform the slope calculations and produce an actionable value for prehospital providers.
The DeO 2 slope may be decreased as a consequence of impaired oxygen metabolism among tissue either with impaired regional perfusion distribution or owning to a lower metabolic rate. Previous studies of the prognostic utility of tissue oximetry have shown that it is predictive of poor outcomes when measured in the hospital setting. 14, 15 Furthermore, StO 2 and VOT-derived parameters are predictive of multisystem organ failure, 12, 14, 15 suggesting that these dynamic parameters may be able to discriminate altered perfusion states. In particular, a decrement in the DeO 2 slope may be explained by different pathophysiologic mechanisms including a reduction in oxygen metabolism (lower metabolic rate) within the monitored tissue, an impaired regional blood flow distribution, or an impairment in oxygen utilization by the mitochondria. Tissue oximetry and VOT-derived parameters may provide a real-time, semicontinuous measurement of regional tissue perfusion in occult shock states. Software modifications could allow for contemporaneous analysis potentially creating a tool to assess the effectiveness of ongoing resuscitation.
Patients in need of LSI did not differ from those not requiring LSI with respect to age, sex, and frequency of penetrating injury. Conventional prehospital variables such as heart and respiratory rate could not differentiate patients requiring LSI from those who did not. The lowest SBP did discriminate between these two groups of patients; however, it did so at levels that would not be actionable by a prehospital provider (122 Ϯ 27 vs. 134 Ϯ 20 mm Hg). Two other parameters predicted the requirement for LSI: GCS, a wellknown triage and prognostic indicator and the VOT-derived parameters. Interestingly, baseline oximetric values also do not differ significantly between the groups. Previous studies have noted changes in baseline StO 2 associated with MOD scale and mortality but may not address compensated or occult shock states. This is an inherent limitation of the technology in that peripheral vasoconstriction associated with compensated shock states may be accompanied by a reduction in regional tissue oxygen demand and compromised supply. However, stressing the system by producing a vascular occlusion yields parameters such as the ReO 2 and DeO 2 slopes which differentiate those patients requiring LSI from those that did not (Table 1) .
To further evaluate the VOT-derived parameters, we constructed a model that incorporates data elements that are available to prehospital providers and differ between the LSI and control cohorts. Using multiple logistic regression, we demonstrate that DeO 2 impairment is associated with LSI irrespective of GCS and blood pressure. Furthermore, DeO 2 slope did not correlate with SBP (Fig. 1, A) , despite SBP being an accepted indicator of hypoperfusion. This may be explained by the fact that SBP and DeO 2 assess hypoperfusion at different levels. SBP, just as central venous oxygen saturation is a global indicator of hypoperfusion, whereas DeO 2 is a more regional marker of perfusion deficits. Decreasing DeO 2 slope is associated with an increase in ISS. Our findings are supported by previous published data showing that there is no association between global parameters of perfusion and StO 2 , or VOT-derived parameters. 17 These data suggest that DeO 2 may be used as a prehospital triage tool to identify a group of patients in need of LSI.
Lactate is also used as a surrogate to assess prehospital hypoperfusion. 18 In-flight lactate levels did not discriminate between patients requiring LSI from those who did not. Furthermore, there was no association between lactate levels and DeO 2 as expected. This may be explained by the fact that lactate accumulation usually lags behind the initial insult. Moreover, this discrepancy between DeO 2 and lactate may indicate that DeO 2 is capable of detecting occult shock, defined as persistent occult hypoperfusion in the setting of normal vital signs and lactate levels.
We think that DeO 2 has several advantages for prehospital trauma risk stratification of patients that require LSI and intensive in-hospital therapy. Patients with a low DeO 2 slope may benefit from earlier triage to Level I trauma centers, even when they have no apparent vital sign abnormality, respiratory distress, or altered sensorium. This study does not address titration of prehospital resuscitation and its impact on both DeO 2 and the subsequent need for LSI. Additional data are required to establish whether a tool such as tissue oximetry may be used to guide prehospital resuscitative therapy. If such application would be successful, then it might help in decreasing indiscriminate use of crystalloid solutions that are known to worsen dilutional coagulopathy and hemorrhage. 19, 20 In conjunction with vital signs and neurologic assessment, tissue oximetry may allow for the selection of a patient population that would benefit from early resuscitation while minimizing patient exposure to isotonic fluids. Furthermore, tissue oximetry using serial VOT may be able to guide therapy providing both feedback on the efficacy of treatment and an endpoint for resuscitation.
Our study indicates that tissue oximetry measured during patient transport provides additional prognostic information about LSI in the absence of clinically apparent shock, respiratory distress, and altered sensorium. A prospective validation in unselected trauma patients is necessary before widespread adoption of tissue oxygenation by prehospital providers. Future implementation might include using DeO 2 as part of a decision aid to identify and direct the need for aggressive prehospital and emergency department resuscitation.
LIMITATIONS
The patient populations transported by our air medical service are predominantly blunt trauma victims, of higher acuity, and may not be broadly generalizable to trauma patients at large. We collected data from April to September and thus did not evaluate the performance of the device in cold weather. A bias for high acuity patients likely exists, as minor trauma patients would be sent by ground to local facilities. Despite the high acuity of these patients, mortality was low (3%), perhaps indicating a selection bias. This cohort of patients may not include some patients with short flight times or patients who were in extremis. In these cases, tissue oximetry is not necessary to identify severe illness or initiate early resuscitation.
CONCLUSION
Prehospital DeO 2 is associated with need for LSI in our trauma population. Further study of DeO 2 is warranted to determine whether it can be used as an adjunct triage criterion or an endpoint for resuscitation.
